Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -655 | -3,014 | -2,063 | -1,040 | -427 |
| Depreciation Amortization | 14 | 20 | 7 | 7 | 3 |
| Accounts payable and accrued liabilities | -67 | -118 | -270 | 100 | -29 |
| Other Working Capital | -108 | 452 | 337 | 586 | 145 |
| Other Operating Activity | 67 | 636 | 788 | -66 | 54 |
| Operating Cash Flow | $-750 | $-2,024 | $-1,202 | $-413 | $-253 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -172 | -145 | N/A | N/A |
| Investing Cash Flow | $-2 | $-172 | $-145 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 30 | 30 | N/A |
| Debt Issued | N/A | 104 | N/A | N/A | N/A |
| Other Financing Activity | -3 | 3,000 | 3,088 | 374 | 351 |
| Financing Cash Flow | $-3 | $3,104 | $3,118 | $404 | $351 |
| Beginning Cash Position | 930 | 22 | 22 | 22 | 22 |
| End Cash Position | 176 | 930 | 1,793 | 13 | 119 |
| Net Cash Flow | $-754 | $909 | $1,772 | $-9 | $98 |
| Free Cash Flow | |||||
| Operating Cash Flow | -750 | -2,024 | -1,202 | -413 | -253 |
| Capital Expenditure | -2 | -172 | -145 | N/A | N/A |
| Free Cash Flow | -752 | -2,195 | -1,346 | -413 | -253 |